Indiana § 4-22-2.3-8 Board of pharmacy interim rules

Indiana Statutes

§ 4-22-2.3-8 — Board of pharmacy interim rules

Indiana § 4-22-2.3-8

Art. 22ADMINISTRATIVE RULES AND PROCEDURES

Ch. 2.3Transitional Provisions; Exceptions to Rulemaking

This text of Indiana § 4-22-2.3-8 (Board of pharmacy interim rules) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 4-22-2.3-8 (2026).

Text

(a)The Indiana board of pharmacy, on its own initiative or under a written request from the state police department, the United States Drug Enforcement Administration, or a poison control center, may adopt interim rules under IC 4-22-2-37.2 to declare a substance is a synthetic drug if the board finds that the substance:

(1)has been scheduled or emergency scheduled by the United States Drug Enforcement Administration;

(2)has been scheduled, emergency scheduled, or criminalized by another state; or

(3)has:

(A)a high potential for abuse; and

(B)no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.

(b)In making a determination under subsection (a)(3), the Indiana board of pharmacy shall consider the following

Free access — add to your briefcase to read the full text and ask questions with AI

(a) The Indiana board of pharmacy, on its own
initiative or under a written request from the state police department,
the United States Drug Enforcement Administration, or a poison
control center, may adopt interim rules under IC 4-22-2-37.2 to declare
a substance is a synthetic drug if the board finds that the substance:
(1) has been scheduled or emergency scheduled by the United
States Drug Enforcement Administration;
(2) has been scheduled, emergency scheduled, or criminalized by
another state; or
(3) has:
(A) a high potential for abuse; and
(B) no accepted medical use in treatment in the United States
or lacks accepted safety for use in treatment under medical
supervision.
(b) In making a determination under subsection (a)(3), the Indiana
board of pharmacy shall consider the following factors relating to the
substance:
(1) The actual or relative potential for abuse.
(2) Scientific evidence of the substance's pharmacological effect,
if known.
(3) The state of scientific knowledge regarding the substance.
(4) The history and current pattern of abuse of the substance.
(5) The scope, duration, and significance of abuse of the
substance.
(6) The degree of risk to the public health.
(7) The psychic or psychological dependence liability of the
substance.
(c) Notwithstanding IC 4-22-2-37.2(i), a rule described in this
section becomes effective when the rule is published in the Indiana
Register. A rule described in this section expires not later than June 30
of the year following the year in which the rule is accepted for filing by
the publisher of the Indiana Register and may not be continued in
another interim rule.